- Home
- XFOR vs NEWT Comparison
XFOR vs NEWT Comparison
Compare XFOR & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | NEWT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | 143 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 395.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | XFOR | NEWT |
|---|---|---|
| Price | $4.45 | $14.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $9.00 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 340.8K | 175.7K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.45 |
| P/E Ratio | ★ N/A | $5.99 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $9.59 |
| 52 Week High | $4.83 | $14.91 |
Technical Indicators
Market Signals| Indicator | XFOR | NEWT |
|---|---|---|
| Relative Strength Index (RSI) | 58.48 | 70.19 |
| Support Level | $3.41 | $11.46 |
| Resistance Level | $4.57 | $14.91 |
| Average True Range (ATR) | 0.25 | 0.48 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 68.84 | 99.47 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.